Skip to main content
. 2024 Aug 29;17:3759–3767. doi: 10.2147/IDR.S475917

Table 1.

Baseline Characteristics of Study Patients

Number of patients 95
Men, n (%) 64 (67.4)
Age, years
 Mean ± SD 72.1 ± 11.6
 < 60, n (%) 14 (14.7)
 ≥ 60 to < 70, n (%) 20 (21.1)
 ≥ 70 to < 75, n (%) 19 (20.0)
 ≥ 75 to <80, n (%) 18 (18.9)
 ≥ 80 to <85, n (%) 13 (13.7)
 ≥ 85, n (%) 11 (11.6)
BMI, kg/m2
 Mean ± SD 22.6 ± 3.2
 < 18.5, n (%) 10 (10.5)
 ≥ 18.5 to 25.0, n (%) 66 (69.5)
 ≥ 25.0, n (%) 19 (20.0)
Smoker, n (%) 9 (9.5)
Kidney status
 Not on dialysis, n (%) 29 (30.5)
 On dialysis, n (%) 66 (69.5)
Systolic BP, mmHg
 Mean ± SD 147.3 ± 26.3
 < 140, n (%) 36 (37.9)
 ≥ 140, n (%) 58 (61.1)
 N/A, n (%) 1 (1.0)
Diastolic BP, mmHg
 Mean ± SD 77.7 ± 15.6
 < 90, n (%) 75 (78.9)
 ≥ 90, n (%) 19 (20.0)
 N/A, n (%) 1 (1.1)
Total cholesterol, mg/dL
 Mean ± SD 145.6 ± 31.1
 < 175, n (%) 67 (70.5)
 ≥ 175, n (%) 12 (12.6)
 N/A, n (%) 16 (16.8)
Triglyceride, mg/dL
 Mean ± SD 136.0 ± 82.2
 < 150, n (%) 60 (63.2)
 ≥ 150, n (%) 28 (29.5)
 N/A, n (%) 7 (7.4)
Charlson Comorbidity index, n (%)
 Median (interquartile range) 8 (6–9)
 < 8 46 (48.4)
 ≥ 8 49 (51.6)
HbA1c, %
 Mean ± SD 6.7 ± 0.9
 < 7, n (%) 64 (67.4)
 ≥ 7, n (%) 31 (32.6)
Serum glucose, mg/dl
 Mean ± SD 175.7 (58.8)
 < 126 13 (13.7)
 ≥ 126 82 (86.3)
TyG indexa
 Mean ± SD 9.2 ± 0.7
 < 9 33 (34.7)
 ≥ 9 55 (57.9)
 N/A, n (%) 7 (7.4)
Diabetes medications, n (%)
 Insulin, n (%) 17 (17.9)
 GLP1 receptor agonists, n (%) 33 (34.7)
 DPP4 inhibitors, n (%) 52 (54.7)
 SGLT2 inhibitors, n (%) 2 (2.1)
 Sulfonylureas, n (%) 22 (23.2)
 Otherb, n (%) 5 (5.3)

Notes: aTyG index = ln[serum glucose (mg/dl) × triglyceride (mg/dl)/2]. bOther diabetes medications include acarbose, pioglitazone, metformin hydrochloride, and voglibose.

Abbreviations: BMI, body mass index; BP, blood pressure; TyG index, triglyceride-glucose index.